BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, Macdonald PS, Hopper I, Kistler PM, Briffa T, Wong J, Abhayaratna W, Thomas L, Audehm R, Newton P, O'loughlin J, Branagan M, Connell C. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. Heart, Lung and Circulation 2018;27:1123-208. [DOI: 10.1016/j.hlc.2018.06.1042] [Cited by in Crossref: 122] [Cited by in F6Publishing: 152] [Article Influence: 30.5] [Reference Citation Analysis]
Number Citing Articles
1 Palmer K, Bowles K, Morphet J. The heartache of living with failure: The experience of people with chronic heart failure. Collegian 2022. [DOI: 10.1016/j.colegn.2022.09.010] [Reference Citation Analysis]
2 Chan E, Rooprai J, Rodger J, Visintini S, Rodger N, Philip S, Mielniczuk L, Sun LY. Sex-based differences in referral of heart failure patients to outpatient clinics: a scoping review. ESC Heart Fail 2022. [PMID: 36069110 DOI: 10.1002/ehf2.14143] [Reference Citation Analysis]
3 Ganes A, Davis JA, Virtanen JK, Voutilainen A, Tuomainen T, Atherton JJ, Amerena J, Driscoll A, Hare DL, Wittert G, Ruusunen A, Marx W, Mohebbi M, O’neil A. Urinary sodium concentration predicts time to major adverse coronary events and all-cause mortality in men with heart failure over a 28–33-year period: a prospective cohort study. BMC Cardiovasc Disord 2022;22. [DOI: 10.1186/s12872-022-02830-3] [Reference Citation Analysis]
4 Louis M, Hwang R, Sabapathy S, Roberts LA, Morris NR. Small Muscle Mass Training in Heart Failure: A Scoping Review of The Literature. J Cardiopulm Rehabil Prev 2022;42:373-5. [PMID: 35940822 DOI: 10.1097/HCR.0000000000000721] [Reference Citation Analysis]
5 Callaghan EM, Diamandis-Nikoletatos E, van Leeuwen PP, Higgins JB, Somerville CE, Brown LJ, Schumacher TL. Communication regarding the deactivation of implantable cardioverter-defibrillators: A scoping review and narrative summary of current interventions. Patient Educ Couns 2022:S0738-3991(22)00391-3. [PMID: 36055906 DOI: 10.1016/j.pec.2022.08.011] [Reference Citation Analysis]
6 Holland DJ, Stanton T. Reply to: Myocarditis and Cardiac Complications Associated with COVID-19 and mRNA Vaccination. Heart Lung Circ 2022:S1443-9506(22)00982-9. [PMID: 35933261 DOI: 10.1016/j.hlc.2022.07.002] [Reference Citation Analysis]
7 Mohammed Shariful Islam S, Halooq A, Dening J, Uddin R, Laranjo L, Chow CK, Maddison R. Healthcare providers’ perspectives on using smart home systems to improve self-management and care in people with heart failure: A qualitative study. International Journal of Medical Informatics 2022. [DOI: 10.1016/j.ijmedinf.2022.104837] [Reference Citation Analysis]
8 Xanthopoulos A, Giamouzis G, Skoularigis J, Triposkiadis F. Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost? World J Cardiol 2022; 14(7): 438-445 [DOI: 10.4330/wjc.v14.i7.438] [Reference Citation Analysis]
9 Oya T, Sato J, Maezawa K, Shiba N, Takeda M, Momose Y. Efficacy and safety of tolvaptan in chronic heart failure. Pharmacy Practice and Res. [DOI: 10.1002/jppr.1814] [Reference Citation Analysis]
10 Karamichalakis N, Xanthopoulos A, Triposkiadis F, Paraskevaidis I, Tsougos E. Reshaping Treatment of Heart Failure with Preserved Ejection Fraction. JCM 2022;11:3706. [DOI: 10.3390/jcm11133706] [Reference Citation Analysis]
11 Al-Omary MS, Majeed T, Al-Khalil H, Sugito S, Clapham M, Ngo DTM, Attia JR, Boyle AJ, Sverdlov AL. Patient characteristics, short-term and long-term outcomes after incident heart failure admissions in a regional Australian setting. Open Heart 2022;9:e001897. [PMID: 35641098 DOI: 10.1136/openhrt-2021-001897] [Reference Citation Analysis]
12 Sivanathan V, Smallwood N, Strathmore A, Johnson D, Le B, Zentner D. The Palliative Approach and Terminal Heart Failure Admissions - Are We Getting it Right? Heart Lung Circ 2022;31:841-8. [PMID: 35153151 DOI: 10.1016/j.hlc.2022.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Singh GK, Ferguson C, Hickman LD. Integrating Heart Failure Palliative Care Delivery in an Uncertain Disease Trajectory. Heart Lung Circ 2022;31:755-6. [PMID: 35589205 DOI: 10.1016/j.hlc.2022.04.001] [Reference Citation Analysis]
14 Kruik-Kollöffel WJ, Vallejo-Yagüe E, Movig KLL, Linssen GCM, Heintjes EM, van der Palen J. Non-cardiovascular medication and readmission for heart failure: an observational cohort study. Int J Clin Pharm 2022. [PMID: 35633434 DOI: 10.1007/s11096-022-01418-3] [Reference Citation Analysis]
15 Mueller M, Siegenthaler J, Fäh D, Schuetz P. [Nutrition in Case of Heart Failure]. Praxis (Bern 1994) 2022;111:375-80. [PMID: 35611481 DOI: 10.1024/1661-8157/a003860] [Reference Citation Analysis]
16 Yuan M, Ren F, Gao D, Zhou H. The Value of SII in Predicting the Mortality of Patients with Heart Failure. Disease Markers 2022;2022:1-10. [DOI: 10.1155/2022/3455372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Filipiak KJ, Surma S, Romańczyk M, Okopień B. Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10. JCDD 2022;9:161. [DOI: 10.3390/jcdd9050161] [Reference Citation Analysis]
18 McBeath KCC, Angermann CE, Cowie MR. Digital Technologies to Support Better Outcome and Experience of Care in Patients with Heart Failure. Curr Heart Fail Rep 2022. [PMID: 35486314 DOI: 10.1007/s11897-022-00548-z] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 McDonagh J, Prichard R, Ferguson C, Phillips JL, Davidson PM, Macdonald PS, Newton PJ. Clinician Estimates of Frailty Compared to Formal Frailty Assessment in Adults With Heart Failure: A Cross-Sectional Analysis. Heart Lung Circ 2022:S1443-9506(22)00141-X. [PMID: 35501244 DOI: 10.1016/j.hlc.2022.04.003] [Reference Citation Analysis]
20 Kleissl-muir S, Rasmussen B, Owen A, Zinn C, Driscoll A. Low Carbohydrate Diets for Diabetic Cardiomyopathy: A Hypothesis. Front Nutr 2022;9:865489. [DOI: 10.3389/fnut.2022.865489] [Reference Citation Analysis]
21 Ursaru AM, Petris AO, Costache II, Nicolae A, Crisan A, Tesloianu ND. Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD-What We Still Don't Know. J Cardiovasc Dev Dis 2022;9:120. [PMID: 35448096 DOI: 10.3390/jcdd9040120] [Reference Citation Analysis]
22 Walton N, Buttery AK. National Heart Foundation of Australia welcomes new standards in cardiology for pharmacy services. Pharmacy Practice and Res 2022;52:5-6. [DOI: 10.1002/jppr.1798] [Reference Citation Analysis]
23 Giuliano C, Vicendese D, Vogrin S, Lane R, Driscoll A, Dinh D, Palmer K, Levinger I, Neil C. Predictors of Referral to Cardiac Rehabilitation in Patients following Hospitalisation with Heart Failure: A Multivariate Regression Analysis. J Clin Med 2022;11:1232. [PMID: 35268323 DOI: 10.3390/jcm11051232] [Reference Citation Analysis]
24 Warner V, Nguyen D, Bayles T, Hopper I. Management of heart failure in older people. Pharmacy Practice and Res. [DOI: 10.1002/jppr.1796] [Reference Citation Analysis]
25 Pizzi J, Livori A, Connell C, Hort A, Prosser A, Zhang C, Ziser K, Munro C, Mellor Y. Standard of practice in cardiology for pharmacy services. Pharmacy Practice and Res. [DOI: 10.1002/jppr.1795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Jones JL, Lumsden NG, Simons K, Ta'eed A, de Courten MP, Wijeratne T, Cox N, Neil CJA, Manski-Nankervis JA, Hamblin PS, Janus ED, Nelson CL. Using electronic medical record data to assess chronic kidney disease, type 2 diabetes and cardiovascular disease testing, recognition and management as documented in Australian general practice: a cross-sectional analysis. Fam Med Community Health 2022;10:e001006. [PMID: 35177470 DOI: 10.1136/fmch-2021-001006] [Reference Citation Analysis]
27 Barnett A, Beasley R, Buchan C, Chien J, Farah CS, King G, McDonald CF, Miller B, Munsif M, Psirides A, Reid L, Roberts M, Smallwood N, Smith S. Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults: 'Swimming between the flags'. Respirology 2022. [PMID: 35178831 DOI: 10.1111/resp.14218] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Osekowski M, Trytell A, La Gerche A, Prior D, MacIsaac A, Paratz ED. A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy. Am J Cardiovasc Drugs 2022. [PMID: 35157254 DOI: 10.1007/s40256-022-00523-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Boy Y, Enç N. A scale development study for evaluating the dietary behaviors of patients with heart failure. Heart Lung 2022;53:61-6. [PMID: 35151047 DOI: 10.1016/j.hrtlng.2022.01.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kott KA, Bishop M, Yang CHJ, Plasto TM, Cheng DC, Kaplan AI, Cullen L, Celermajer DS, Meikle PJ, Vernon ST, Figtree GA. Biomarker Development in Cardiology: Reviewing the Past to Inform the Future. Cells 2022;11:588. [PMID: 35159397 DOI: 10.3390/cells11030588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Henkens MTHM, Weerts J, Verdonschot JAJ, Raafs AG, Stroeks S, Sikking MA, Amin H, Mourmans SGJ, Geraeds CBG, Sanders-van Wijk S, Barandiarán Aizpurua A, Uszko-Lencer NHMK, Krapels IPC, Wolffs PFG, Brunner HG, van Leeuwen REW, Verhesen W, Schalla SM, van Stipdonk AWM, Knackstedt C, Li X, Abdul Hamid MA, van Paassen P, Hazebroek MR, Vernooy K, Brunner-La Rocca HP, van Empel VPM, Heymans SRB. Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry. ESC Heart Fail 2022. [PMID: 35118823 DOI: 10.1002/ehf2.13833] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Nourse R, Lobo E, Mcvicar J, Kensing F, Islam SMS, Kayser L, Maddison R. Characteristics of smart health ecosystems that support self-care among people with heart failure: A scoping review (Preprint). JMIR Cardio. [DOI: 10.2196/36773] [Reference Citation Analysis]
33 Damy T, Benedyga V, Pezel T, Berthelot E, Gauthier J, Habib G, Iliou MC, Aupetit JF, Baudry G, De Groote P, Logeart D, Chaufourier L, Ciobotaru V, Pousset F, Beauvais F, Bauer F, Zores F, Lairez O, Richard K, Hittinger L, Teiger E, Taieb C, Audureau E. Prescription, Compliance, and Burden Associated with Salt-Restricted Diets in Heart Failure Patients: Results from the French National OFICSel Observatory. Nutrients 2022;14:308. [PMID: 35057490 DOI: 10.3390/nu14020308] [Reference Citation Analysis]
34 Kwan T, Chua B, Pires D, Feng O, Edmiston N, Longman J. A qualitative analysis of the barriers and enablers faced by Australian rural general practitioners in the non-pharmacological management of congestive heart failure in community dwelling patients. BMC Health Serv Res 2022;22:5. [PMID: 34974834 DOI: 10.1186/s12913-021-07383-3] [Reference Citation Analysis]
35 Cui Y, Yang M, Zhu J, Zhang H, Duan Z, Wang S, Liao Z, Liu W. Developments in diagnostic applications of saliva in Human Organ Diseases. Medicine in Novel Technology and Devices 2022. [DOI: 10.1016/j.medntd.2022.100115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Appay M, Croft H, Mcivor D. Virtual Pharmacy; A Novel Adjunct to Cardiac Rehabilitation. Heart, Lung and Circulation 2022;31:S302-3. [DOI: 10.1016/j.hlc.2022.06.520] [Reference Citation Analysis]
37 Vishwanath S, Qaderi V, Steves CJ, Reid CM, Hopper I, Ryan J. Cognitive decline and risk of dementia in individuals with heart failure: A systematic review and meta-analysis. J Card Fail 2021:S1071-9164(21)00529-7. [PMID: 34971812 DOI: 10.1016/j.cardfail.2021.12.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Yao F, Zhang Y, Kuang X, Zhou Q, Huang L, Peng J, Hou K, Du S. Effects of Cardiac Rehabilitation Training in Patients with Heart Failure Based on Traditional Chinese Exercise: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2021;2021:1068623. [PMID: 34819979 DOI: 10.1155/2021/1068623] [Reference Citation Analysis]
39 Swaraj S, Kozor R, Arnott C, Di Bartolo BA, A Figtree G. Heart Failure with Reduced Ejection Fraction-Does Sex Matter? Curr Heart Fail Rep 2021;18:345-52. [PMID: 34778933 DOI: 10.1007/s11897-021-00533-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
40 Bagheri H, Shakeri S, Nazari AM, Goli S, Khajeh M, Mardani A, Vlaisavljevic Z. Effectiveness of nurse-led counselling and education on self-efficacy of patients with acute coronary syndrome: A randomized controlled trial. Nurs Open 2021. [PMID: 34766453 DOI: 10.1002/nop2.1129] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Engstrom N, Dobson G, Ng K, Letson H. Fragmented QRS is associated with ventricular arrhythmias in heart failure patients: A systematic review and meta-analysis. Ann Noninvasive Electrocardiol 2021;:e12910. [PMID: 34766402 DOI: 10.1111/anec.12910] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Chan RK, Dinh DT, Hare DL, Lockwood S, Neil C, Prior D, Brennan A, Lefkovits J, Carruthers H, Reid CM, Driscoll A; VCOR-HF Investigators. Management of Acute Decompensated Heart Failure in Rural Versus Metropolitan Settings: An Australian Experience. Heart Lung Circ 2021:S1443-9506(21)01238-5. [PMID: 34740540 DOI: 10.1016/j.hlc.2021.08.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Sindone AP, Haikerwal D, Audehm RG, Neville AM, Lim K, Parsons RW, Piazza P, Liew D. Clinical characteristics of people with heart failure in Australian general practice: results from a retrospective cohort study. ESC Heart Fail 2021. [PMID: 34708559 DOI: 10.1002/ehf2.13661] [Reference Citation Analysis]
44 Oliveira MI, Leite S, Barros A, Lourenço AP, Mendes C, Schmidt C, Santos M, Leite-Moreira A, Moreira-Gonçalves D. Histological and haemodynamic characterization of right ventricle in sedentary and trained rats with heart failure with preserved ejection fraction. Exp Physiol 2021. [PMID: 34676608 DOI: 10.1113/EP089516] [Reference Citation Analysis]
45 Hsu B, Korda RJ, Lindley RI, Douglas KA, Naganathan V, Jorm LR. Use of health and aged care services in Australia following hospital admission for myocardial infarction, stroke or heart failure. BMC Geriatr 2021;21:538. [PMID: 34635068 DOI: 10.1186/s12877-021-02519-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Bezerra Giordan L, Ronto R, Chau JY, Chow C, Laranjo L. Use of mobile applications in heart failure self-management: a qualitative study exploring the patient and primary care clinician perspective (Preprint). JMIR Cardio. [DOI: 10.2196/33992] [Reference Citation Analysis]
47 Singh GK, Ivynian SE, Davidson PM, Ferguson C, Hickman LD. Elements of Integrated Palliative Care in Chronic Heart Failure Across the Care Continuum: A Scoping Review. Heart Lung Circ 2021:S1443-9506(21)01208-7. [PMID: 34593316 DOI: 10.1016/j.hlc.2021.08.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Bezerra L, Tong HL, Atherton JJ, Ronto R, Chau J, Kaye D, Shaw T, Chow C, Laranjo L. Use of mobile applications for heart failure self-management: a systematic review of experimental and qualitative studies (Preprint). JMIR Cardio. [DOI: 10.2196/33839] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol 2021. [PMID: 34531576 DOI: 10.1038/s41569-021-00611-7] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
50 Chen SH, Edwards I, Jayasena R, Ding H, Karunanithi M, Dowling A, Layland J, Maiorana A. Patient Perspectives on Innovative Telemonitoring Enhanced Care Program for Chronic Heart Failure (ITEC-CHF): Usability Study. JMIR Cardio 2021;5:e24611. [PMID: 34519663 DOI: 10.2196/24611] [Reference Citation Analysis]
51 Hsu B, Korda R, Naganathan V, Lewis P, Ooi SY, Brieger D, Jorm L. Burden of cardiovascular diseases in older adults using aged care services. Age Ageing 2021;50:1845-9. [PMID: 34146393 DOI: 10.1093/ageing/afab083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Khandkar C, Patel S, Arnott C. Procedural Volumes in the Era of COVID: The Risk Versus Benefit Trade-Off. Heart Lung Circ 2021;30:1430-2. [PMID: 34364799 DOI: 10.1016/j.hlc.2021.07.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Ambrosy AP, von Haehling S, Kalra PR, Court E, Bhandari S, McDonagh T, Cleland JGF. Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure. Am J Cardiol 2021;152:138-45. [PMID: 34162484 DOI: 10.1016/j.amjcard.2021.04.042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Vaillant MF, Alligier M, Baclet N, Capelle J, Dousseaux MP, Eyraud E, Fayemendy P, Flori N, Guex E, Hennequin V, Lavandier F, Martineau C, Morin MC, Mokaddem F, Parmentier I, Rossi-Pacini F, Soriano G, Verdier E, Zeanandin G, Quilliot D. Guidelines on Standard and Therapeutic Diets for Adults in Hospitals by the French Association of Nutritionist Dieticians (AFDN) and the French Speaking Society of Clinical Nutrition and Metabolism (SFNCM). Nutrients 2021;13:2434. [PMID: 34371943 DOI: 10.3390/nu13072434] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Livori AC, Bishop JL, Ping SE, Oqueli E, Aldrich R, Fitzpatrick AM, Kong DC. Towards OPtimising Care of Regionally-Based Cardiac Patients With a Telehealth Cardiology Pharmacist Clinic (TOPCare Cardiology). Heart, Lung and Circulation 2021;30:1023-30. [DOI: 10.1016/j.hlc.2020.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Inacio MC, Lang C, Bray SCE, Visvanathan R, Whitehead C, Griffith EC, Evans K, Corlis M, Wesselingh S. Health status and healthcare trends of individuals accessing Australian aged care programmes over a decade: the Registry of Senior Australians historical cohort. Intern Med J 2021;51:712-24. [PMID: 32359019 DOI: 10.1111/imj.14871] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
57 Singh GK, Ferguson C, Davidson PM, Newton PJ. Attitudes and practices towards palliative care in chronic heart failure: a survey of cardiovascular nurses and physicians. Contemp Nurse 2021;57:113-27. [PMID: 33970800 DOI: 10.1080/10376178.2021.1928522] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Palazzuoli A, Beltrami M. Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes. Front Cardiovasc Med 2021;8:676658. [PMID: 34095263 DOI: 10.3389/fcvm.2021.676658] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
59 Aerts N, Le Goff D, Odorico M, Le Reste JY, Van Bogaert P, Peremans L, Musinguzi G, Van Royen P, Bastiaens H. Systematic review of international clinical guidelines for the promotion of physical activity for the primary prevention of cardiovascular diseases. BMC Fam Pract 2021;22:97. [PMID: 34011279 DOI: 10.1186/s12875-021-01409-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Lam CSP, Voors AA, Piotr P, McMurray JJV, Solomon SD. Time to rename the middle child of heart failure: heart failure with mildly reduced ejection fraction. Eur Heart J 2020;41:2353-5. [PMID: 32227233 DOI: 10.1093/eurheartj/ehaa158] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
61 Roger VL. Epidemiology of Heart Failure: A Contemporary Perspective. Circ Res 2021;128:1421-34. [PMID: 33983838 DOI: 10.1161/CIRCRESAHA.121.318172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 32] [Article Influence: 1.0] [Reference Citation Analysis]
62 Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-lundqvist C, Boriani G, Castella M, Dan G, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, Meir ML, Lane DA, Lebeau J, Lettino M, Lip GY, Pinto FJ, Neil Thomas G, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL. Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS). Revista Española de Cardiología 2021;74:437.e1-437.e116. [DOI: 10.1016/j.recesp.2020.10.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
63 Silva Almodóvar A, Nahata MC. Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure. Front Pharmacol 2021;12:612941. [PMID: 33995014 DOI: 10.3389/fphar.2021.612941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
64 Sarkies MN, Robinson S, Briffa T, Duffy SJ, Nelson M, Beltrame J, Cullen L, Chew D, Smith J, Brieger D, Macdonald P, Liew D, Reid C. Applying a framework to assess the impact of cardiovascular outcomes improvement research. Health Res Policy Syst 2021;19:67. [PMID: 33882947 DOI: 10.1186/s12961-021-00710-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Naing P, Zhang M, Khine AMT, Aung HS, Chean LN, Liaw J, Bazley M, Vaidya S, Musameh MD, Khan A. Mackay Heart Failure Study: Examining the Root Causes, Compliance With Guideline-Based Therapy and Prognosis. Heart Lung Circ 2021;30:1302-8. [PMID: 33875377 DOI: 10.1016/j.hlc.2021.03.273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 McGee M, Sugito S, Al-Omary MS, Hartnett D, Senanayake T, Hales K, Majeed T, Ngo DTM, Oakley P, Leitch JW, Sverdlov AL, Boyle AJ. Heart failure outcomes in Aboriginal and Torres Strait Islander peoples in the Hunter New England region of New South Wales. Int J Cardiol 2021;334:65-71. [PMID: 33839176 DOI: 10.1016/j.ijcard.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Moran T, Zentner D, Wong J, Philip J, Smallwood N. Chronic breathlessness in advanced cardiorespiratory disease: patient perceptions of opioid use. BMJ Support Palliat Care 2021:bmjspcare-2020-002853. [PMID: 33837113 DOI: 10.1136/bmjspcare-2020-002853] [Reference Citation Analysis]
68 Fusaro M, Tessarin G. Prevention of Coronary Artery Disease-Related Heart Failure: The Role of Computed Tomography Scan. Heart Fail Clin 2021;17:187-94. [PMID: 33673944 DOI: 10.1016/j.hfc.2021.01.005] [Reference Citation Analysis]
69 Gao M, Huang Y, Wang Q, Gu Z, Sun G. Comparative effectiveness of exercise training program in patients with heart failure: protocol for a systematic review of randomised controlled trials and network meta-analysis. BMJ Open 2021;11:e043160. [PMID: 33727267 DOI: 10.1136/bmjopen-2020-043160] [Reference Citation Analysis]
70 Chan DZL, Kerr AJ, Doughty RN. Temporal trends in the burden of heart failure. Intern Med J 2021;51:1212-8. [PMID: 33650267 DOI: 10.1111/imj.15253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, Anker SD, Atherton J, Böhm M, Butler J, Drazner MH, Michael Felker G, Filippatos G, Fiuzat M, Fonarow GC, Gomez-Mesa JE, Heidenreich P, Imamura T, Jankowska EA, Januzzi J, Khazanie P, Kinugawa K, Lam CSP, Matsue Y, Metra M, Ohtani T, Francesco Piepoli M, Ponikowski P, Rosano GMC, Sakata Y, Seferović P, Starling RC, Teerlink JR, Vardeny O, Yamamoto K, Yancy C, Zhang J, Zieroth S. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail 2021;23:352-80. [PMID: 33605000 DOI: 10.1002/ejhf.2115] [Cited by in Crossref: 23] [Cited by in F6Publishing: 152] [Article Influence: 23.0] [Reference Citation Analysis]
72 Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, Anker SD, Atherton J, Böhm M, Butler J, Drazner MH, Felker GM, Filippatos G, Fonarow GC, Fiuzat M, Gomez-Mesa JE, Heidenreich P, Imamura T, Januzzi J, Jankowska EA, Khazanie P, Kinugawa K, Lam CSP, Matsue Y, Metra M, Ohtani T, Francesco Piepoli M, Ponikowski P, Rosano GMC, Sakata Y, SeferoviĆ P, Starling RC, Teerlink JR, Vardeny O, Yamamoto K, Yancy C, Zhang J, Zieroth S. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail 2021:S1071-9164(21)00050-6. [PMID: 33663906 DOI: 10.1016/j.cardfail.2021.01.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 72] [Article Influence: 11.0] [Reference Citation Analysis]
73 Parsonage WA, Chew DP. The Cardiac Society of Australia and New Zealand (CSANZ) Guidelines and Quality Standards Committee: How to use it. A guide for fellows and authors. Heart Lung Circ 2021;30:469-70. [PMID: 33610475 DOI: 10.1016/j.hlc.2021.02.003] [Reference Citation Analysis]
74 Ishikawa Y, Sattler ELP. Nutrition as Treatment Modality in Heart Failure. Curr Atheroscler Rep 2021;23:13. [PMID: 33594492 DOI: 10.1007/s11883-021-00908-5] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
75 Nandal S, Chow CL, Hannah V, Vaddadi G, Van Gaal W. Tolerability and efficacy of sacubitril/valsartan in clinical practice. Intern Med J 2021;51:87-92. [DOI: 10.1111/imj.14749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
76 Choi ES, Wiseman T, Betihavas V. Biomedical, Socioeconomic and Demographic Predictors of Heart Failure Readmissions: A Systematic Review. Heart Lung Circ 2021;30:817-36. [PMID: 33541820 DOI: 10.1016/j.hlc.2020.11.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Sobanski PZ, Krajnik M, Goodlin SJ. Palliative Care for People Living With Heart Disease-Does Sex Make a Difference? Front Cardiovasc Med 2021;8:629752. [PMID: 33634172 DOI: 10.3389/fcvm.2021.629752] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Damarell RA, Morgan DD, Tieman JJ, Healey DF. Multimorbidity through the lens of life-limiting illness: how helpful are Australian clinical practice guidelines to its management in primary care? Aust J Prim Health 2021. [PMID: 33461658 DOI: 10.1071/PY20164] [Reference Citation Analysis]
79 Cartledge S, Maddison R, Vogrin S, Falls R, Tumur O, Hopper I, Neil C. The Utility of Predicting Hospitalizations Among Patients With Heart Failure Using mHealth: Observational Study. JMIR Mhealth Uhealth 2020;8:e18496. [PMID: 33350962 DOI: 10.2196/18496] [Reference Citation Analysis]
80 Mordi IR, Guignard-Duff M, Hall C, New BJM, Lang CC. Use of Population-Based Health Informatics Research to Improve Care for Patients with Cardiovascular Diseases. Diseases 2020;8:E47. [PMID: 33348643 DOI: 10.3390/diseases8040047] [Reference Citation Analysis]
81 Damarell RA, Morgan DD, Tieman JJ, Healey D. Bolstering General Practitioner Palliative Care: A Critical Review of Support Provided by Australian Guidelines for Life-Limiting Chronic Conditions. Healthcare (Basel) 2020;8:E553. [PMID: 33322394 DOI: 10.3390/healthcare8040553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Boulet J, Massie E, Rouleau JL. Heart Failure With Midrange Ejection Fraction-What Is It, If Anything? Can J Cardiol 2021;37:585-94. [PMID: 33276048 DOI: 10.1016/j.cjca.2020.11.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Sallustio BC, Boddy AV. Is there scope for better individualisation of anthracycline cancer chemotherapy? Br J Clin Pharmacol. 2021;87:295-305. [PMID: 33118175 DOI: 10.1111/bcp.14628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
84 Ellis RE, Dodd KJ, Holland AE, Lim K, Tacey M, Shields N. Effect of eccentric exercise on quality of life and function in people with chronic heart failure: a pilot randomised controlled trial. Disabil Rehabil 2020;:1-10. [PMID: 33174464 DOI: 10.1080/09638288.2020.1836679] [Reference Citation Analysis]
85 Dashwood A, Vale C, Laher S, Chui F, Rheault H, Gan J, Wong YW. Impact of Patient and Model of Care Factors on Titration and Tolerability of Sacubitril/Valsartan: An Early Australian Real-World Experience. Heart, Lung and Circulation 2020;29:1688-95. [DOI: 10.1016/j.hlc.2020.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
86 Mcintyre D, Thiagalingam A, Chow C. While you're waiting, a waiting room-based, cardiovascular disease-focused educational program: protocol for a randomised controlled trial. BMJ Open 2020;10:e036780. [PMID: 33082181 DOI: 10.1136/bmjopen-2020-036780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
87 Dashwood A, Vale C, Laher S, Chui F, Hay K, Wong YW. Hypophosphatemia Is Common After Intravenous Ferric Carboxymaltose Infusion Among Patients With Symptomatic Heart Failure With Reduced Ejection Fraction. J Clin Pharmacol 2021;61:515-21. [PMID: 33051909 DOI: 10.1002/jcph.1754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
88 Allida SM, Shehab S, Inglis SC, Davidson PM, Hayward CS, Newton PJ. A RandomisEd ControLled TrIal of ChEwing Gum to RelieVE Thirst in Chronic Heart Failure (RELIEVE-CHF). Heart Lung Circ 2021;30:516-24. [PMID: 33032897 DOI: 10.1016/j.hlc.2020.09.004] [Reference Citation Analysis]
89 El Hadidi S, Samir Bazan N, Byrne S, Darweesh E, Bermingham M. Heart Failure Prescribing Quality at Discharge from a Critical Care Unit in Egypt: The Impact of Multidisciplinary Care. Pharmacy (Basel) 2020;8:E159. [PMID: 32882858 DOI: 10.3390/pharmacy8030159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
90 Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-lundqvist C, Boriani G, Castella M, Dan G, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau J, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, Kirchhof P, Kühne M, Aboyans V, Ahlsson A, Balsam P, Bauersachs J, Benussi S, Brandes A, Braunschweig F, Camm AJ, Capodanno D, Casadei B, Conen D, Crijns HJGM, Delgado V, Dobrev D, Drexel H, Eckardt L, Fitzsimons D, Folliguet T, Gale CP, Gorenek B, Haeusler KG, Heidbuchel H, Iung B, Katus HA, Kotecha D, Landmesser U, Leclercq C, Lewis BS, Mascherbauer J, Merino JL, Merkely B, Mont L, Mueller C, Nagy KV, Oldgren J, Pavlović N, Pedretti RFE, Petersen SE, Piccini JP, Popescu BA, Pürerfellner H, Richter DJ, Roffi M, Rubboli A, Scherr D, Schnabel RB, Simpson IA, Shlyakhto E, Sinner MF, Steffel J, Sousa-uva M, Suwalski P, Svetlosak M, Touyz RM, Dagres N, Arbelo E, Bax JJ, Blomström-lundqvist C, Boriani G, Castella M, Dan G, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau J, Lettino M, Lip GYH, Pinto FJ, Neil Thomas G, Valgimigli M, Van Gelder IC, Watkins CL, Delassi T, Sisakian HS, Scherr D, Chasnoits A, Pauw MD, Smajić E, Shalganov T, Avraamides P, Kautzner J, Gerdes C, Alaziz AA, Kampus P, Raatikainen P, Boveda S, Papiashvili G, Eckardt L, Vassilikos V, Csanádi Z, Arnar DO, Galvin J, Barsheshet A, Caldarola P, Rakisheva A, Bytyçi I, Kerimkulova A, Kalejs O, Njeim M, Puodziukynas A, Groben L, Sammut MA, Grosu A, Boskovic A, Moustaghfir A, Groot ND, Poposka L, Anfinsen O, Mitkowski PP, Cavaco DM, Siliste C, Mikhaylov EN, Bertelli L, Kojic D, Hatala R, Fras Z, Arribas F, Juhlin T, Sticherling C, Abid L, Atar I, Sychov O, Bates MGD, Zakirov NU; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 2021;42:373-498. [DOI: 10.1093/eurheartj/ehaa612] [Cited by in Crossref: 731] [Cited by in F6Publishing: 1818] [Article Influence: 365.5] [Reference Citation Analysis]
91 Guggilla RK, Sowa PM, Jamiolkowski J, Sinnadurai S, Amin A, Kaminski KA. Effects of neurohormonal antagonists on blood pressure in patients with heart failure with reduced ejection fraction (HFrEF): a systematic review protocol. Syst Rev 2020;9:194. [PMID: 32838804 DOI: 10.1186/s13643-020-01452-0] [Reference Citation Analysis]
92 Yao JV, Peters S, Zentner D, James P, Voukelatos J, Kalman J. Emerging role of genetic analysis for stratification of sudden cardiac death risk in dilated cardiomyopathy: An illustrative case. HeartRhythm Case Rep 2020;6:499-502. [PMID: 32817827 DOI: 10.1016/j.hrcr.2020.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Inglis SC, Naismith C, White K, Hendriks JM, Bray J, Hickman LD, Aldridge C, Bardsley K, Cameron J, Candelaria D, Cartledge S, Du H, Ferguson C, Martin L, Selkow T, Xu X, Wynne R, Driscoll A, Gallagher R, Clark R, Davidson PM. CSANZ COVID-19 Cardiovascular Nursing Care Consensus Statement: Executive Summary. Heart Lung Circ 2020;29:1263-7. [PMID: 32859539 DOI: 10.1016/j.hlc.2020.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
94 Halabi A, Sen J, Huynh Q, Marwick TH. Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis. Cardiovasc Diabetol 2020;19:124. [PMID: 32758236 DOI: 10.1186/s12933-020-01100-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
95 Ivynian SE, Ferguson C, Newton PJ, Digiacomo M. Factors influencing care-seeking delay or avoidance of heart failure management: A mixed-methods study. International Journal of Nursing Studies 2020;108:103603. [DOI: 10.1016/j.ijnurstu.2020.103603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
96 Smart NA, Fisher S, Pearson MJ. On “Physical Therapist Clinical Practice Guideline for the Management of Individuals With Heart Failure.” Shoemaker MJ, Dias KJ, Lefebvre KM, Heick JD, Collins SM. Phys Ther. 2020;100:14–43. Physical Therapy 2020;100:1882-1882. [DOI: 10.1093/ptj/pzaa130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
97 Wonggom P, Nolan P, Clark RA, Barry T, Burdeniuk C, Nesbitt K, O'Toole K, Du H. Effectiveness of an avatar educational application for improving heart failure patients' knowledge and self-care behaviors: A pragmatic randomized controlled trial. J Adv Nurs 2020;76:2401-15. [PMID: 32395836 DOI: 10.1111/jan.14414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
98 Savira F, Wang BH, Kompa AR, Ademi Z, Owen AJ, Zoungas S, Tonkin A, Liew D, Zomer E. Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective. European Journal of Preventive Cardiology 2021;28:975-82. [DOI: 10.1177/2047487320938272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
99 Ding H, Jayasena R, Chen SH, Maiorana A, Dowling A, Layland J, Good N, Karunanithi M, Edwards I. The Effects of Telemonitoring on Patient Compliance With Self-Management Recommendations and Outcomes of the Innovative Telemonitoring Enhanced Care Program for Chronic Heart Failure: Randomized Controlled Trial. J Med Internet Res 2020;22:e17559. [PMID: 32673222 DOI: 10.2196/17559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
100 Indraratna P, Tardo D, Yu J, Delbaere K, Brodie M, Lovell N, Ooi SY. Mobile Phone Technologies in the Management of Ischemic Heart Disease, Heart Failure, and Hypertension: Systematic Review and Meta-Analysis. JMIR Mhealth Uhealth 2020;8:e16695. [PMID: 32628615 DOI: 10.2196/16695] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
101 Allida S, Du H, Xu X, Prichard R, Chang S, Hickman LD, Davidson PM, Inglis SC. mHealth education interventions in heart failure. Cochrane Database Syst Rev 2020;7:CD011845. [PMID: 32613635 DOI: 10.1002/14651858.CD011845.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
102 Prasad SB, Lin A, Kwan C, Sippel J, Younger JF, Hammett C, Thomas L, Atherton JJ. Determinants of Diastolic Dysfunction Following Myocardial Infarction: Evidence for Causation Beyond Infarct Size. Heart Lung Circ 2020;29:1815-22. [PMID: 32601021 DOI: 10.1016/j.hlc.2020.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Du H, Wonggom P, Burdeniuk C, Wight J, Nolan P, Barry T, Nesbitt K, Clark RA. Development and feasibility testing of an interactive avatar education application for education of patients with heart failure. British Journal of Cardiac Nursing 2020;15:1-13. [DOI: 10.12968/bjca.2020.0007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Jennings GL. Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease. Med J Aust 2020;212:502-503.e1. [PMID: 32441063 DOI: 10.5694/mja2.50622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
105 Krówczyńska D, Jankowska-Polańska B. Nurses as educators in the comprehensive heart failure care programme-Are we ready for it? Nurs Open 2020;7:1354-66. [PMID: 32802356 DOI: 10.1002/nop2.507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
106 Cuscaden C, Ramsay SC, Prasad S, Goodwin B, Smith J. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol 2020. [PMID: 32385832 DOI: 10.1007/s12350-020-02152-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
107 Triposkiadis F, Xanthopoulos A, Butler J. From PARADIGM to PARAGON further evidence supporting continuous heart failure spectrum. Eur J Heart Fail 2020;22:1536-9. [PMID: 32294294 DOI: 10.1002/ejhf.1837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
108 Planinc I, Milicic D, Cikes M. Telemonitoring in Heart Failure Management. Card Fail Rev 2020;6:e06. [PMID: 32377385 DOI: 10.15420/cfr.2019.12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
109 Giuliano C, Levinger I, Vogrin S, Neil CJ, Allen JD. PRIME-HF: Novel Exercise for Older Patients with Heart Failure. A Pilot Randomized Controlled Study. J Am Geriatr Soc 2020;68:1954-61. [PMID: 32293033 DOI: 10.1111/jgs.16428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
110 Yang TWW, Johari Y, Burton PR, Earnest A, Shaw K, Hare JL, Brown WA. Bariatric Surgery in Patients with Severe Heart Failure. OBES SURG 2020;30:2863-9. [DOI: 10.1007/s11695-020-04612-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
111 Sessa M, Rasmussen DB, Jensen MT, Kragholm K, Torp-Pedersen C, Andersen M. Metoprolol Versus Carvedilol in Patients With Heart Failure, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, and Renal Failure. Am J Cardiol 2020;125:1069-76. [PMID: 32000982 DOI: 10.1016/j.amjcard.2019.12.048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
112 Branca L, Sbolli M, Metra M, Fudim M. Heart failure with mid-range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines. ESC Heart Fail 2020;7:381-99. [PMID: 32239646 DOI: 10.1002/ehf2.12586] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
113 Younger J, Lo A, Mccormack L, Mcgaughran J, Prasad S, Atherton JJ. Hypertrophic Cardiomyopathy: Challenging the Status Quo? Heart, Lung and Circulation 2020;29:556-65. [DOI: 10.1016/j.hlc.2019.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
114 Peters S, Johnson R, Birch S, Zentner D, Hershberger RE, Fatkin D. Familial Dilated Cardiomyopathy. Heart, Lung and Circulation 2020;29:566-74. [DOI: 10.1016/j.hlc.2019.11.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
115 Kistler PM, Atherton JJ, Jennings G. Clarification of the Australian heart failure guideline recommendation for primary prevention defibrillator implantation in non-ischaemic cardiomyopathy. Med J Aust 2020;212:509-510.e1. [PMID: 32200548 DOI: 10.5694/mja2.50551] [Reference Citation Analysis]
116 Gard E, Nanayakkara S, Kaye D, Gibbs H. Management of heart failure with preserved ejection fraction. Aust Prescr 2020;43:12-7. [PMID: 32139957 DOI: 10.18773/austprescr.2020.006] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
117 Singh GK, Ramjan L, Ferguson C, Davidson PM, Newton PJ. Access and referral to palliative care for patients with chronic heart failure: A qualitative study of healthcare professionals. J Clin Nurs 2020;29:1576-89. [PMID: 32141656 DOI: 10.1111/jocn.15222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Rørth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, Køber L, Prescott MF, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, Mcmurray JJ. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Circ: Heart Failure 2020;13. [DOI: 10.1161/circheartfailure.119.006541] [Cited by in Crossref: 17] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
119 Singh GK, Ivynian SE, Ferguson C, Davidson PM, Newton PJ. Palliative care in chronic heart failure: a theoretically guided, qualitative meta-synthesis of decision-making. Heart Fail Rev 2020;25:457-67. [PMID: 31900788 DOI: 10.1007/s10741-019-09910-1] [Reference Citation Analysis]
120 Khan MS, Jones DW, Butler J. Salt, No Salt, or Less Salt for Patients With Heart Failure? Am J Med 2020;133:32-8. [PMID: 31419422 DOI: 10.1016/j.amjmed.2019.07.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
121 Lazar S, Rayner B, Lopez Campos G, Mcgrath K, Mcclements L. Mechanisms of heart failure with preserved ejection fraction in the presence of diabetes mellitus. Translational Metabolic Syndrome Research 2020;3:1-5. [DOI: 10.1016/j.tmsr.2020.04.002] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Kjeldsen SE, von Lueder TG, Smiseth OA, Wachtell K, Mistry N, Westheim AS, Hopper I, Julius S, Pitt B, Reid CM, Devereux RB, Zannad F. Medical Therapies for Heart Failure With Preserved Ejection Fraction. Hypertension 2020;75:23-32. [PMID: 31786973 DOI: 10.1161/HYPERTENSIONAHA.119.14057] [Cited by in Crossref: 15] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
123 Cartledge S, Thomas E, Hollier K, Maddison R. Development of standardised programme content for phase II cardiac rehabilitation programmes in Australia using a modified Delphi process. BMJ Open 2019;9:e032279. [PMID: 31796485 DOI: 10.1136/bmjopen-2019-032279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
124 Zhang X, Broszczak D, Kostner K, Guppy-Coles KB, Atherton JJ, Punyadeera C. Salivary Protein Panel to Diagnose Systolic Heart Failure. Biomolecules 2019;9:E766. [PMID: 31766659 DOI: 10.3390/biom9120766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
125 Zhang X, Karunathilaka N, Senanayake S, Subramaniam VN, Chan W, Kostner K, Fraser J, Atherton JJ, Punyadeera C. The potential prognostic utility of salivary galectin-3 concentrations in heart failure. Clin Res Cardiol 2020;109:685-92. [PMID: 31598750 DOI: 10.1007/s00392-019-01557-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
126 Perera K, Ademi Z, Liew D, Zomer E. Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis. European Journal of Preventive Cardiology 2021;28:966-72. [DOI: 10.1177/2047487319878953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
127 Dobbe L, Rahman R, Elmassry M, Paz P, Nugent K. Cardiogenic Pulmonary Edema. Am J Med Sci 2019;358:389-97. [PMID: 31813466 DOI: 10.1016/j.amjms.2019.09.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
128 Ferry OR, Huang YC, Masel PJ, Hamilton M, Fong KM, Bowman RV, McKenzie SC, Yang IA. Diagnostic approach to chronic dyspnoea in adults. J Thorac Dis 2019;11:S2117-28. [PMID: 31737340 DOI: 10.21037/jtd.2019.10.53] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
129 Sciatti E, Dallapellegrina L, Metra M, Lombardi CM. New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may hold. Journal of Cardiovascular Medicine 2019;20:650-9. [DOI: 10.2459/jcm.0000000000000850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
130 Newton PJ, Si S, Reid CM, Davidson PM, Hayward CS, Macdonald PS; NSW HF Snapshot Investigators. Survival After an Acute Heart Failure Admission. Twelve-Month Outcomes From the NSW HF Snapshot Study. Heart Lung Circ 2020;29:1032-8. [PMID: 31708454 DOI: 10.1016/j.hlc.2019.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
131 Grigorescu ED, Lacatusu CM, Floria M, Mihai BM, Cretu I, Sorodoc L. Left Ventricular Diastolic Dysfunction in Type 2 Diabetes-Progress and Perspectives. Diagnostics (Basel) 2019;9:E121. [PMID: 31533216 DOI: 10.3390/diagnostics9030121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
132 Ivynian SE, Ferguson C, Davidson PM. Time to re-think the terminology of heart failure? European Journal of Cardiovascular Nursing 2019;18:648-50. [DOI: 10.1177/1474515119874538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Clark RA, Marin TS, McCarthy AL, Bradley J, Grover S, Peters R, Karapetis CS, Atherton JJ, Koczwara B. Cardiotoxicity after cancer treatment: a process map of the patient treatment journey. Cardiooncology 2019;5:14. [PMID: 32154020 DOI: 10.1186/s40959-019-0046-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
134 Yu JJ, Sunderland Y. Outcomes of hospital in the home treatment of acute decompensated congestive cardiac failure compared to traditional in-hospital treatment in older patients. Australas J Ageing 2020;39:e77-85. [PMID: 31325230 DOI: 10.1111/ajag.12697] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Briffa T, Atherton JJ, Connell C. Response to "Paradise Lost? New National Heart Foundation of Australia Guidelines on Heart Failure Fail to Recognise the Intensity of Exercise Evidence". Heart Lung Circ 2020;29:e9. [PMID: 31320257 DOI: 10.1016/j.hlc.2019.06.721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Marketou ME, Maragkoudakis S, Fragiadakis K, Konstantinou J, Patrianakos A, Kassotakis S, Anastasiou I, Alevizaki A, Kostaki A, Chlouverakis G, Vardas PE, Parthenakis FI. Long‐term outcome of hypertensive patients with heart failure with mid‐range ejection fraction: The significance of blood pressure control. J Clin Hypertens 2019;21:1124-31. [DOI: 10.1111/jch.13626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
137 Catchpool M, Ramchand J, Martyn M, Hare DL, James PA, Trainer AH, Knight J, Goranitis I. A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy. Genet Med 2019;21:2815-22. [PMID: 31222143 DOI: 10.1038/s41436-019-0582-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
138 Lau DH, Kalman JM, Sanders P. Primary prevention implantable cardioverter defibrillators in non-ischaemic cardiomyopathy: challenging the Australian heart failure guidelines. Med J Aust 2019;211:154-155.e1. [PMID: 31216054 DOI: 10.5694/mja2.50248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
139 Nikolaou M, Chrysohoou C, Georgilas TA, Giamouzis G, Giannakoulas G, Karavidas A, Papadopoulos C, Patsilinakos S, Tziakas D, Parissis J; Hellenic Iron Consensus Group. Management of iron deficiency in chronic heart failure: Practical considerations for clinical use and future directions. Eur J Intern Med 2019;65:17-25. [PMID: 31109847 DOI: 10.1016/j.ejim.2019.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
140 Iyngkaran P, Thomas M, Majoni SW. Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials - What do we Consolidate and how do we Plan for the Future? Curr Cardiol Rev 2019;15:158-60. [PMID: 31084591 DOI: 10.2174/1573403X1503190506101720] [Reference Citation Analysis]
141 Prasad SB, Holland DJ, Atherton JJ, Whalley G. New Diastology Guidelines: Evolution, Validation and Impact on Clinical Practice. Heart Lung Circ 2019;28:1411-20. [PMID: 31064714 DOI: 10.1016/j.hlc.2019.03.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
142 Smart NA. Paradise Lost? New National Heart Foundation of Australia Guidelines on Heart Failure Fail to Recognise the Intensity of Exercise Evidence. Heart Lung Circ 2019;28:827-8. [PMID: 30777656 DOI: 10.1016/j.hlc.2018.12.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Cleland JGF, van Veldhuisen DJ, Ponikowski P. The year in cardiology 2018: heart failure. European Heart Journal 2019;40:651-61. [DOI: 10.1093/eurheartj/ehz010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
144 Taylor CJ, Ordóñez-Mena JM, Roalfe AK, Lay-Flurrie S, Jones NR, Marshall T, Hobbs FDR. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. BMJ 2019;364:l223. [PMID: 30760447 DOI: 10.1136/bmj.l223] [Cited by in Crossref: 96] [Cited by in F6Publishing: 135] [Article Influence: 32.0] [Reference Citation Analysis]
145 Dinatolo E, Sciatti E, Anker MS, Lombardi C, Dasseni N, Metra M. Updates in heart failure: what last year brought to us. ESC Heart Fail 2018;5:989-1007. [PMID: 30570225 DOI: 10.1002/ehf2.12385] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
146 Bhaskaran A, Tung R, Stevenson WG, Kumar S. Catheter Ablation of VT in Non-Ischaemic Cardiomyopathies: Endocardial, Epicardial and Intramural Approaches. Heart, Lung and Circulation 2019;28:84-101. [DOI: 10.1016/j.hlc.2018.10.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
147 Adsett JA, Morris NR, Kuys SS, Paratz JD, Mudge AM. Motivators and barriers for participation in aquatic and land-based exercise training programs for people with stable heart failure: A mixed methods approach. Heart Lung 2019;48:287-93. [PMID: 30528166 DOI: 10.1016/j.hrtlng.2018.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
148 Smart NA, Taylor R, Walker S, Warren F, Ciani O, Davos CH, Piepoli M. Exercise training for chronic heart failure (ExTraMATCH II): Why all data are not equal. Eur J Prev Cardiolog 2019;26:1229-31. [DOI: 10.1177/2047487318815314] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
149 Singh GK, Davidson PM, Macdonald PS, Newton PJ. The use of hospital-based services by heart failure patients in the last year of life: a discussion paper. Heart Fail Rev 2019;24:199-207. [DOI: 10.1007/s10741-018-9751-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
150 Moskovitch J, Voskoboinik A. Cardiac resynchronization therapy: a comprehensive review. Minerva Med 2019;110:121-38. [PMID: 30334442 DOI: 10.23736/S0026-4806.18.05861-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
151 Campbell RT, Petrie MC, Mcmurray JJ. Redefining heart failure phenotypes based on ejection fraction. Eur J Heart Fail 2018;20:1634-5. [DOI: 10.1002/ejhf.1325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
152 Cleland JFG, Clark RA. Telehealth: delivering high-quality care for heart failure. The Lancet 2018;392:990-1. [DOI: 10.1016/s0140-6736(18)31995-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
153 Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, Macdonald PS, Hopper I, Kistler P, Briffa TG, Wong J, Abhayaratna WP, Thomas L, Audehm R, Newton PJ, Oˈloughlin J, Connell C, Branagan M. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018. Medical Journal of Australia 2018;209:363-9. [DOI: 10.5694/mja18.00647] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]